JP6106777B2 - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP6106777B2 JP6106777B2 JP2016026822A JP2016026822A JP6106777B2 JP 6106777 B2 JP6106777 B2 JP 6106777B2 JP 2016026822 A JP2016026822 A JP 2016026822A JP 2016026822 A JP2016026822 A JP 2016026822A JP 6106777 B2 JP6106777 B2 JP 6106777B2
- Authority
- JP
- Japan
- Prior art keywords
- value
- organic
- mass
- iob
- external preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 34
- 230000000699 topical effect Effects 0.000 title description 2
- 239000003921 oil Substances 0.000 claims description 31
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 20
- 229920001577 copolymer Polymers 0.000 claims description 20
- 150000003904 phospholipids Chemical class 0.000 claims description 19
- 229920002401 polyacrylamide Polymers 0.000 claims description 18
- 150000002148 esters Chemical class 0.000 claims description 16
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 235000012000 cholesterol Nutrition 0.000 claims description 8
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229940068065 phytosterols Drugs 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- -1 biphenyl compound Chemical class 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 28
- 239000000284 extract Substances 0.000 description 26
- 239000000126 substance Substances 0.000 description 20
- 235000014113 dietary fatty acids Nutrition 0.000 description 19
- 239000000194 fatty acid Substances 0.000 description 19
- 229930195729 fatty acid Natural products 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 125000004432 carbon atom Chemical group C* 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 10
- 230000001953 sensory effect Effects 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000002537 cosmetic Substances 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 7
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 6
- 229940106189 ceramide Drugs 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 5
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 5
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 235000010290 biphenyl Nutrition 0.000 description 5
- 239000004305 biphenyl Substances 0.000 description 5
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 5
- 238000013112 stability test Methods 0.000 description 5
- OYAQUBKYAKSHOA-UHFFFAOYSA-N 2-(2-hydroxy-5-propylphenyl)-4-propylphenol Chemical compound CCCC1=CC=C(O)C(C=2C(=CC=C(CCC)C=2)O)=C1 OYAQUBKYAKSHOA-UHFFFAOYSA-N 0.000 description 4
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 4
- 229940031569 diisopropyl sebacate Drugs 0.000 description 4
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- BJRXGOFKVBOFCO-UHFFFAOYSA-N 2-hydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(C)O BJRXGOFKVBOFCO-UHFFFAOYSA-N 0.000 description 3
- ZIIVEKCKOPDBLT-UHFFFAOYSA-N 2-octyldodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)O)CCCCCCCC ZIIVEKCKOPDBLT-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- 244000301850 Cupressus sempervirens Species 0.000 description 3
- 235000011511 Diospyros Nutrition 0.000 description 3
- 244000236655 Diospyros kaki Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000736199 Paeonia Species 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- 244000128206 Pyracantha coccinea Species 0.000 description 3
- 235000003105 Pyracantha coccinea Nutrition 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 125000003172 aldehyde group Chemical group 0.000 description 3
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 3
- WPKYZIPODULRBM-UHFFFAOYSA-N azane;prop-2-enoic acid Chemical compound N.OC(=O)C=C WPKYZIPODULRBM-UHFFFAOYSA-N 0.000 description 3
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940124274 edetate disodium Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 3
- 229940071085 lauroyl glutamate Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229940077397 octyldodecyl lactate Drugs 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 125000002328 sterol group Chemical group 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 2
- OBMREGPCBAUGQT-UHFFFAOYSA-N 2-ethylhexyl 4-(1,3,5-triazin-2-ylamino)benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC=NC=N1 OBMREGPCBAUGQT-UHFFFAOYSA-N 0.000 description 2
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- 235000003840 Amygdalus nana Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 241000269333 Caudata Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- 241000272185 Falco Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229920002367 Polyisobutene Polymers 0.000 description 2
- 241000220299 Prunus Species 0.000 description 2
- 235000011432 Prunus Nutrition 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000242583 Scyphozoa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 240000007313 Tilia cordata Species 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- KZENBFUSKMWCJF-UHFFFAOYSA-N [5-[5-[5-(hydroxymethyl)-2-thiophenyl]-2-furanyl]-2-thiophenyl]methanol Chemical compound S1C(CO)=CC=C1C1=CC=C(C=2SC(CO)=CC=2)O1 KZENBFUSKMWCJF-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229920006322 acrylamide copolymer Polymers 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000005233 alkylalcohol group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940099417 ceramide 2 Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000005020 hydroxyalkenyl group Chemical group 0.000 description 2
- 229940001447 lactate Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000014774 prunus Nutrition 0.000 description 2
- 229940056692 resinol Drugs 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- OQQOAWVKVDAJOI-UHFFFAOYSA-N (2-dodecanoyloxy-3-hydroxypropyl) dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCC OQQOAWVKVDAJOI-UHFFFAOYSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical class C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- RMZFJNNOMUICLE-UHFFFAOYSA-N 1-hexanoyloxypropan-2-yl hexanoate Chemical compound CCCCCC(=O)OCC(C)OC(=O)CCCCC RMZFJNNOMUICLE-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- HFWHTGSLDKKCMD-UHFFFAOYSA-N 2,2-bis(octanoyloxymethyl)butyl octanoate Chemical compound CCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC HFWHTGSLDKKCMD-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- JAFZDVXJYZJAAF-UHFFFAOYSA-N 2-(2-decanoyloxyethoxy)ethyl decanoate Chemical compound CCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCC JAFZDVXJYZJAAF-UHFFFAOYSA-N 0.000 description 1
- FZGBADVTTLOFPU-UHFFFAOYSA-N 2-(2-dodecanoyloxyethoxy)ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCC FZGBADVTTLOFPU-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- BXCRLBBIZJSWNS-UHFFFAOYSA-N 2-hydroxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCO BXCRLBBIZJSWNS-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 1
- HTNFLUQQANUSLR-UHFFFAOYSA-N 2-octanoyloxyethyl octanoate Chemical compound CCCCCCCC(=O)OCCOC(=O)CCCCCCC HTNFLUQQANUSLR-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- OCOAAZPOBSWYQB-UHFFFAOYSA-N 9,10,16-trihydroxy-n-(2-hydroxy-3-tetradecoxypropyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCOCC(O)CNC(=O)CCCCCCCC(O)C(O)CCCCCCO OCOAAZPOBSWYQB-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000006054 Agastache cana Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 240000008027 Akebia quinata Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 244000294263 Arctium minus Species 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- 240000006914 Aspalathus linearis Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- XWOJJAOAUXZFNG-UHFFFAOYSA-N C(C)N(C1=CC(=C(C(=O)C(COCC(CCCC)C(C2=C(C=C(C=C2)N(CC)CC)O)=O)CCCC)C=C1)O)CC Chemical compound C(C)N(C1=CC(=C(C(=O)C(COCC(CCCC)C(C2=C(C=C(C=C2)N(CC)CC)O)=O)CCCC)C=C1)O)CC XWOJJAOAUXZFNG-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000009025 Carya illinoensis Nutrition 0.000 description 1
- 244000068645 Carya illinoensis Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 235000005903 Dioscorea Nutrition 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 235000000504 Dioscorea villosa Nutrition 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000758993 Equisetidae Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 240000007058 Halophila ovalis Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical class OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- IEZRNEGTKRQRFV-LFBNJJMOSA-N N-octadecanoyl-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC IEZRNEGTKRQRFV-LFBNJJMOSA-N 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 241000183666 Nepsera aquatica Species 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000001439 Opuntia Species 0.000 description 1
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000287882 Pavo Species 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241001483078 Phyto Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002651 Polysorbate 85 Polymers 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 241000589157 Rhizobiales Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000899950 Salix glauca Species 0.000 description 1
- 241001072909 Salvia Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 241000219995 Wisteria Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000981595 Zoysia japonica Species 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- CFAFEJHONLMPQY-UHFFFAOYSA-N beta-Dimethylamino-aethan-alpha-sulfonsaeure Natural products CN(C)CCS(O)(=O)=O CFAFEJHONLMPQY-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229940073579 ethanolamine hydrochloride Drugs 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940074049 glyceryl dilaurate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- ASKIVFGGGGIGKH-UHFFFAOYSA-N isostearic acid monoglyceride Natural products CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 1
- 150000003903 lactic acid esters Chemical class 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N monoethanolamine hydrochloride Natural products NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229940113171 polysorbate 85 Drugs 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- ARJOQCYCJMAIFR-UHFFFAOYSA-N prop-2-enoyl prop-2-enoate Chemical compound C=CC(=O)OC(=O)C=C ARJOQCYCJMAIFR-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 1
- 229940039790 sodium oxalate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 108010021724 tonin Proteins 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、保湿感の持続性に優れ、かつ、きしみ感を抑えた感触の良好な皮膚外用剤に関する。 The present invention relates to an external preparation for skin having excellent moisturizing feeling and good touch with reduced squeaky feeling.
水酸基を有するビフェニル化合物が優れたチロシナーゼ活性阻害効果、及びメラニン生成抑制効果を有するとともに安全性が高く、美白化粧料の配合成分として有用であることが知られている(特許文献1、2)。セラミド、コレステロールは細胞膜の構成や維持に必要な成分であり、これらを皮膚に適応することで、皮膚の状態を良好にすることができることが知られている。また、紫外線吸収剤は、皮膚および組成物の紫外線からのダメージを防ぐため、多くの化粧品に用いられており、近年、2−(4−ジエチルアミノ−2−ヒドロキシベンゾイル)−安息香酸へキシルエテル等のUVA紫外線吸収剤の利用が進んでいる。 It is known that a biphenyl compound having a hydroxyl group has an excellent tyrosinase activity inhibitory effect and melanin production inhibitory effect and is highly safe, and is useful as a component for whitening cosmetics (Patent Documents 1 and 2). Ceramide and cholesterol are components necessary for the composition and maintenance of cell membranes, and it is known that the skin condition can be improved by adapting them to the skin. In addition, ultraviolet absorbers are used in many cosmetics in order to prevent damage to the skin and the composition from ultraviolet rays. Recently, 2- (4-diethylamino-2-hydroxybenzoyl) -hexyl ether such as 2- (4-diethylamino-2-hydroxybenzoyl) benzoate is used. The use of UVA ultraviolet absorbers is progressing.
しかしながら、これらの物質は、常温で粉末又は固体状であるものが多く、それ自体は安定であるが、水に対して不溶又は溶解性が低く、さらに非極性油に対する溶解性も低いという難溶性物質であることが知られている。このため、これら難溶性物質を十分な効果を奏する量配合した皮膚外用剤を得ることは困難であった。
そこで、これらの難溶性物質を、化粧料に代表される皮膚外用剤に安定に配合すべく、特定の極性油(ジカルボン酸又はその誘導体、イソステアリン酸モノグリセリル、リン酸トリアルキルエステル、乳酸アルキルエステル、プロピレングリコール脂肪酸エステル等)と併用することで皮膚外用剤中に安定に配合することが提案されている(特許文献3〜7参照)。
However, many of these substances are powders or solids at room temperature and are stable per se, but are insoluble or poorly soluble in water, and also have poor solubility in nonpolar oils. It is known to be a substance. For this reason, it has been difficult to obtain an external preparation for skin in which these hardly soluble substances are blended in a sufficient amount.
Therefore, specific polar oils (dicarboxylic acid or derivatives thereof, monoglyceryl isostearate, trialkyl ester phosphate, alkyl lactate ester) are used to stably blend these poorly soluble substances into external preparations such as cosmetics. , Propylene glycol fatty acid ester, etc.) and the like have been proposed to be stably blended into an external preparation for skin (see Patent Documents 3 to 7).
しかしながら、これら特定の極性油と難溶性物質とを含有する皮膚外用剤は、感触的にはすべりがよく、さらさらとしているため、さっぱりとした仕上がり感が得られる反面、きしみを強く感じたり、保湿感を感じづらかったりすることが分かった。また、難溶性物質を溶解させようと、極性油を多量に皮膚外用剤に配合すると、安定性を保つことも難しくなってくることも判明した。
従って、本発明の課題は、難溶性物質を安定に配合してなり、かつ良好な保湿感と使用感を有する皮膚外用剤を提供することにある。
However, since these external preparations containing specific polar oils and poorly soluble substances are slippery and feel smooth, a refreshing finish can be obtained, but a squeaky or moisturizing feel can be obtained. I found out that it was difficult to feel the feeling. It has also been found that if a large amount of polar oil is blended in a skin external preparation to dissolve a hardly soluble substance, it becomes difficult to maintain stability.
Therefore, the subject of this invention is providing the skin external preparation which mix | blends a poorly soluble substance stably and has a favorable moisturizing feeling and a usability | use_condition.
そこで、本発明者らは、難溶性物質の溶解性を改善し、極性油の影響による使用感の低下を改善すべく、種々の成分の検討を行った結果、難溶性物質、極性油に加え、ポリアクリルアミド化合物とリン脂質を併用して用いると、使用感がよく、さらに安定性にも優れることを見出し、本発明を完成するに至った。 Therefore, as a result of studying various components in order to improve the solubility of the hardly soluble substance and to improve the decrease in the feeling of use due to the influence of the polar oil, the present inventors have added the insoluble substance to the polar oil. When the polyacrylamide compound and the phospholipid are used in combination, it has been found that the feeling of use is good and the stability is excellent, and the present invention has been completed.
すなわち、本発明は、次の成分(A)〜(D)を含有することを特徴とする皮膚外用剤を提供するものである。
(A)一般式(1)又は(2)で表されるビフェニル化合物、コレステロール、フィトステロール、セラミド及び25℃で固体の紫外線吸収剤よりなる群から選択される1種以上
(B)IOB値が0.3〜0.5の極性油
(C)ポリアクリルアミド化合物
(D)リン脂質
That is, this invention provides the skin external preparation characterized by containing the following component (A)-(D).
(A) One or more selected from the group consisting of a biphenyl compound represented by the general formula (1) or (2), cholesterol, phytosterol, ceramide, and a solid UV absorber at 25 ° C. (B) IOB value is 0 .3 to 0.5 polar oil (C) polyacrylamide compound (D) phospholipid
(式中、R1及びR2は、それぞれ水素原子又は炭素数1〜10の直鎖若しくは分岐鎖のアルキル基若しくはアルケニル基を示す) (Wherein R 1 and R 2 each represent a hydrogen atom or a linear or branched alkyl group or alkenyl group having 1 to 10 carbon atoms)
(式中、R3及びR4は、それぞれ炭素数1〜5の直鎖若しくは分岐鎖のアルキル基、アルケニル基、ヒドロキシアルキル基若しくはヒドロキシアルケニル基、アルデヒド基、又はアセチル基を示す) (Wherein R 3 and R 4 each represent a linear or branched alkyl group, alkenyl group, hydroxyalkyl group or hydroxyalkenyl group, aldehyde group or acetyl group having 1 to 5 carbon atoms)
本発明によれば、極性油に由来するきしみ感を抑え、保湿感を感じやすくさせ、さらに難溶性物質を安定的に配合できる。特に難溶性物質を2種以上併用した場合、析出が生じやすい傾向があるが、本発明の皮膚外用剤では、難溶性物質を2種以上併用した場合においても、良好な感触を維持しつつ、安定性に優れた皮膚外用剤を提供することができる。 According to the present invention, it is possible to suppress a squeaky feeling derived from polar oil, make it easy to feel a moisturizing feeling, and to stably add a hardly soluble substance. In particular, when two or more kinds of poorly soluble substances are used in combination, precipitation tends to occur. However, in the external preparation for skin of the present invention, even when two or more kinds of hardly soluble substances are used in combination, while maintaining a good feel, An external preparation for skin having excellent stability can be provided.
本発明で用いられる(A)下記一般式(1)又は(2)で表されるビフェニル化合物、セラミド、コレステロール、フィトステロール及び25℃で固体の紫外線吸収剤から選ばれる1種又は2種以上は、25℃で固体であり、水に対して不溶又は溶解性が低く、さらに非極性油に対する溶解性も低い物質として知られている。 (A) One or more selected from (A) a biphenyl compound represented by the following general formula (1) or (2), ceramide, cholesterol, phytosterol and a solid UV absorber at 25 ° C. It is known as a substance that is solid at 25 ° C., is insoluble or has low solubility in water, and has low solubility in nonpolar oils.
下記一般式(1)又は(2)で表されるビフェニル化合物は、常温で粉末状の物質で、優れたチロシナーゼ活性阻害効果及びメラニン生成抑制効果を有することが知られている公知の物質である。例えばジクレオソール、テトラヒドロジオイゲノール、テトラヒドロマグノロール等を挙げることができる。これらのビフェニル化合物は、常法により合成して用いることもでき、また、植物などから得たものを水添して用いることもできる。 The biphenyl compound represented by the following general formula (1) or (2) is a known substance that is a powdery substance at room temperature and is known to have an excellent tyrosinase activity inhibitory effect and melanin production inhibitory effect. . For example, dichloroeosol, tetrahydrodioigenol, tetrahydromagnolol and the like can be mentioned. These biphenyl compounds can be synthesized and used by a conventional method, or those obtained from plants and the like can be hydrogenated.
(式中、R1及びR2は、それぞれ水素原子又は炭素数1〜10の直鎖若しくは分岐鎖のアルキル基若しくはアルケニル基を示す) (Wherein R 1 and R 2 each represent a hydrogen atom or a linear or branched alkyl group or alkenyl group having 1 to 10 carbon atoms)
(式中、R3及びR4は、それぞれ炭素数1〜5の直鎖若しくは分岐鎖のアルキル基、アルケニル基、ヒドロキシアルキル基若しくはヒドロキシアルケニル基、アルデヒド基、又はアセチル基を示す) (Wherein R 3 and R 4 each represent a linear or branched alkyl group, alkenyl group, hydroxyalkyl group or hydroxyalkenyl group, aldehyde group or acetyl group having 1 to 5 carbon atoms)
これらのうち、その美白効果と安定性の点から、一般式(1)においてR1及びR2としては、水素原子、又は炭素数1〜10の直鎖のアルキル基が好ましく、炭素数1〜8の直鎖のアルキル基がより好ましい。一般式(2)においてR3及びR4としては、炭素数1〜5の直鎖若しくは分岐鎖のアルキル基若しくはヒドロキシアルキル基、アルデヒド基、又はアセチル基が好ましく、炭素数1〜3の直鎖のアルキル基がより好ましい。さらに好ましくは、2,2’−ジヒドロキシ−5,5’−ジ−n−プロピルビフェニル(一般式(1):R1及びR2がC2H5)であることが好ましい。 Among these, from the viewpoint of its whitening effect and stability, as the R 1 and R 2 in the general formula (1), a hydrogen atom, or a straight-chain alkyl group having 1 to 10 carbon atoms preferably from 1 to carbon atoms Eight linear alkyl groups are more preferred. In the general formula (2), R 3 and R 4 are preferably a linear or branched alkyl group having 1 to 5 carbon atoms, a hydroxyalkyl group, an aldehyde group, or an acetyl group, and a linear chain having 1 to 3 carbon atoms. The alkyl group is more preferable. More preferably, it is preferably 2,2′-dihydroxy-5,5′-di-n-propylbiphenyl (general formula (1): R 1 and R 2 are C 2 H 5 ).
一般式(1)において、R1及びR2の具体例としては、それぞれH、CH3、C2H5、C3H7、C4H9、C5H11、C6H13、C7H15、C8H17等から選択される1種が挙げられる。一般式(2)において、R3及びR4の具体例としては、それぞれCH3、C2H5、C3H7、CH2OH、C3H6OH、CHO、COCH3、CH2CH=CH2等から選択される1種が挙げられる。 In the general formula (1), specific examples of R 1 and R 2 are H, CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 11 , C 6 H 13 , C, respectively. One type selected from 7 H 15 , C 8 H 17 and the like can be mentioned. In the general formula (2), specific examples of R 3 and R 4 are CH 3 , C 2 H 5 , C 3 H 7 , CH 2 OH, C 3 H 6 OH, CHO, COCH 3 , CH 2 CH, respectively. = 1 type selected from CH 2 and the like.
セラミドとしては、一般にタイプ1〜タイプ6と言われる各種構造のセラミドを挙げることができる。スフィンゴシンあるいはフィトスフィンゴシンのいずれかを骨格とし、アミド結合により、脂肪酸、α−ヒドロキシ酸あるいはω−ヒドロキシ酸が結合している。これには、脂肪酸の炭素数及び不飽和度の異なるいくつかの化合物がある。いずれも結晶性が高く、融点も高いので、製剤中に安定的に配合するのが難しい物質である。これらのうち、市場での入手し易さから、好ましくは、(2S,3R)−2−オクタデカノイルアミノオクタデカン−1,3−ジオール(以下セラミド2と表す)、N−2−ヒドロキシステアロイルフィトスフィンゴシン(以下セラミド6と表す)である。これらは、動植物からの抽出あるいは合成によって得られるが、これらに限定するものではない。
具体的には、N−ステアロイルフィトスフィンゴシン(日光ケミカルズ社製)、セラミドHO3(クローダジャパン社製)、セラミド2(高砂香料工業社製TIC−001)等が挙げられる。
Examples of the ceramide include ceramides having various structures generally referred to as type 1 to type 6. Either sphingosine or phytosphingosine is used as a skeleton, and fatty acid, α-hydroxy acid or ω-hydroxy acid is bonded by an amide bond. There are several compounds with different fatty acid carbon numbers and unsaturation levels. All of them are high in crystallinity and have a high melting point, so that they are difficult to be stably mixed in a preparation. Of these, (2S, 3R) -2-octadecanoylaminooctadecane-1,3-diol (hereinafter referred to as ceramide 2), N-2-hydroxystearoyl phyto is preferable because of easy availability in the market. Sphingosine (hereinafter referred to as ceramide 6). These are obtained by extraction or synthesis from animals and plants, but are not limited thereto.
Specifically, N-stearoyl phytosphingosine (made by Nikko Chemicals), ceramide HO3 (made by Croda Japan), ceramide 2 (TIC-001 made by Takasago International Corporation), etc. are mentioned.
コレステロールやフィトステロールは、ステロール骨格を有し、水には溶解せず、油剤にも溶解しにくい物質である。フィトステロールとしては、β−シトステロール、スチグマステロール及びカンペステロールを含有する物質を挙げることができる。
市販されているものとしては、Presome C−I(日本精化株式会社)、Presome CSII−101(日本精化株式会社)、Phytopresome(日本精化株式会社)等を挙げることができる。
Cholesterol and phytosterol are substances that have a sterol skeleton, do not dissolve in water, and are difficult to dissolve in oils. Examples of phytosterols include substances containing β-sitosterol, stigmasterol, and campesterol.
As what is marketed, Presome CI (Nippon Seika Co., Ltd.), Presome CSII-101 (Nippon Seika Co., Ltd.), Phytopresome (Nippon Seika Co., Ltd.), etc. can be mentioned.
25℃で固体の紫外線吸収剤としては、2−(4−ジエチルアミノ−2−ヒドロキシベンゾイル)安息香酸へキシルエステル、2,4,6−トリス〔4−(2−エチルヘキシルオキシカルボニル)アニリノ〕−1,3,5−トリアジン、ジエチルヘキシルブタミドトリアゾン、4−tert−ブチル−4’−メトキシ−ジベンゾイルメタン等を挙げることができる。
これらは市販されており、UVINUL A PLUS(2−(4−ジエチルアミノ−2−ヒドロキシベンゾイル)安息香酸へキシルエステル;BASF社製)、UVINUL T−150(2,4,6−トリス[4−(2−エチルヘキシルオキシカルボニル)アニリノ]−1,3,5−トリアジン;BASF社製)、ジエチルヘキシルブタミドトリアゾンはUVASORB HEB(3V GROUP社製)等が挙げられる。
Examples of the UV absorber solid at 25 ° C. include 2- (4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester, 2,4,6-tris [4- (2-ethylhexyloxycarbonyl) anilino] -1 , 3,5-triazine, diethylhexylbutamide triazone, 4-tert-butyl-4′-methoxy-dibenzoylmethane and the like.
These are commercially available, UVINUL A PLUS (2- (4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester; manufactured by BASF), UVINUL T-150 (2,4,6-tris [4- ( 2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine (manufactured by BASF), diethylhexylbutamide triazone includes UVASORB HEB (manufactured by 3V GROUP) and the like.
前記(A)成分のうち、一般式(1)又は(2)で表されるビフェニル化合物、セラミド、コレステロール、フィトステロール、2−(4−ジエチルアミノ−2−ヒドロキシベンゾイル)安息香酸ヘキシルエステル、2,4,6−トリス[4−(2−エチルヘキシルオキシカルボニル)アニリノ]−1,3,5−トリアジン、ジエチルヘキシルブタミドトリアゾン及び4−tert−ブチル−4’−メトキシ−ジベンゾイルメタンから選ばれる1種又は2種以上が好ましい。本発明では、これらの成分の2種以上を含有する場合であっても、安定に配合でき、かつ良好な保湿感と使用感が得られる。 Among the components (A), the biphenyl compound represented by the general formula (1) or (2), ceramide, cholesterol, phytosterol, 2- (4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester, 2,4 1,6-tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine, diethylhexylbutamidotriazone and 4-tert-butyl-4′-methoxy-dibenzoylmethane Species or two or more are preferred. In the present invention, even when two or more of these components are contained, a stable moisturizing feeling and a feeling of use can be obtained.
本発明皮膚外用剤における(A)成分の含有量は、安定性、官能特性の点から、皮膚外用剤総量に対して、0.01〜8質量%が好ましく、より好ましくは0.05〜5質量%、さらに好ましくは0.1〜3質量%である。 The content of the component (A) in the external preparation for skin of the present invention is preferably 0.01 to 8% by mass, more preferably 0.05 to 5%, based on the total amount of external preparation for skin, from the viewpoints of stability and sensory characteristics. It is 0.1 mass%, More preferably, it is 0.1-3 mass%.
本発明における(B)極性油は、IOB値が0.3〜0.5の油性成分である。IOB値とは、Inorganic/Organic Balance(無機性/有機性比)の略であって、化合物の有機値に対する化合物の無機値の比に対応する値であり、有機化合物の極性の度合いを示す指標である。具体的には、IOB値=無機性値/有機性値として表される。 The (B) polar oil in the present invention is an oily component having an IOB value of 0.3 to 0.5. The IOB value is an abbreviation for Inorganic / Organic Balance (inorganic / organic ratio), and is a value corresponding to the ratio of the inorganic value of the compound to the organic value of the compound, and is an index indicating the degree of polarity of the organic compound It is. Specifically, it is expressed as IOB value = inorganic value / organic value.
ここで、「無機性値」、「有機性値」のそれぞれについては、例えば、分子中の炭素原子1個について「有機性値」が20、同水酸基1個について「無機性値」が100といったように、各種原子又は官能基に応じた「無機性値」、「有機性値」が設定されており、有機化合物中の全ての原子及び官能基の「無機性値」、「有機性値」を積算することによって、当該有機化合物のIOB値が算出される(例えば、甲田善生 著、「有機概念図―基礎と応用―」11頁〜17頁、三共出版 1984年発行 参照)。 Here, for each of the “inorganic value” and “organic value”, for example, “organic value” is 20 for one carbon atom in the molecule, and “inorganic value” is 100 for one hydroxyl group. As described above, “inorganic value” and “organic value” corresponding to various atoms or functional groups are set, and “inorganic value” and “organic value” of all atoms and functional groups in the organic compound. Is integrated to calculate the IOB value of the organic compound (see, for example, Yoshio Koda, “Organic Conceptual Diagram—Basics and Applications”, pages 11-17, published by Sankyo Publishing, 1984).
(B)IOB値が0.3〜0.5の極性油としては、安定性と保湿感の点から、(i)有機性値が700以下でIOB値が0.3〜0.5の極性油、及び(ii)有機性値が1000以上でIOB値が0.3〜0.5のN−アシルアミノ酸エステルから選ばれる極性油が好ましい。より好ましくは、(i)有機性値が200〜600でIOB値が0.3〜0.5の極性油、及び(ii)有機性値が1100〜1300でIOB値が0.3〜0.5のN−アシルアミノ酸エステルから選ばれる極性油であり、さらに好ましくは(i)有機性値が250〜450でIOB値が0.3〜0.5の極性油、及び(ii)有機性値が1150〜1250でIOB値が0.3〜0.5のN−アシルアミノ酸エステルから選ばれる極性油である。 (B) As a polar oil having an IOB value of 0.3 to 0.5, from the viewpoint of stability and moisturizing feeling, (i) a polarity having an organic value of 700 or less and an IOB value of 0.3 to 0.5 Preferred are polar oils selected from oils and (ii) N-acyl amino acid esters having an organic value of 1000 or more and an IOB value of 0.3 to 0.5. More preferably, (i) a polar oil with an organic value of 200-600 and an IOB value of 0.3-0.5, and (ii) an organic value of 1100-1300 with an IOB value of 0.3-0. A polar oil selected from 5 N-acylamino acid esters, more preferably (i) a polar oil having an organic value of 250 to 450 and an IOB value of 0.3 to 0.5, and (ii) an organic value. Is a polar oil selected from N-acylamino acid esters having 1150 to 1250 and an IOB value of 0.3 to 0.5.
(B)IOB値が0.3〜0.5の極性油の含有量は、皮膚外用剤総量に対して、安定性官能性の点から、1〜40質量%が好ましく、より好ましくは1〜15質量%であり、さらに好ましくは3〜13質量%である。 (B) The content of the polar oil having an IOB value of 0.3 to 0.5 is preferably 1 to 40% by mass, more preferably 1 to 40% by mass with respect to the total amount of the external preparation for skin. It is 15 mass%, More preferably, it is 3-13 mass%.
(B)IOB値が0.3〜0.5の極性油は、1種でも2種以上を混合して用いてもよいが、安定性と保湿感の点から、(i)有機性値が700以下でIOB値が0.3〜0.5の極性油と、(ii)有機性値が1000以上でIOB値が0.3〜0.5のN−アシルアミノ酸エステルを併用することが好ましい。より好ましくは、(i)有機性値が200〜600でIOB値が0.3〜0.5の極性油と、(ii)有機性値が1100〜1300でIOB値が0.3〜0.5のN−アシルアミノ酸エステルを併用するものであり、さらに好ましくは(i)有機性値が250〜450でIOB値が0.3〜0.5の極性油と、(ii)有機性値が1150〜1250でIOB値が0.3〜0.5のN−アシルアミノ酸エステルを併用するものである。 (B) Polar oils having an IOB value of 0.3 to 0.5 may be used alone or in combination of two or more. However, from the viewpoint of stability and moisturizing feeling, (i) the organic value is It is preferable to use a polar oil having an IOB value of not more than 700 and an IOB value of 0.3 to 0.5, and (ii) an N-acyl amino acid ester having an organic value of not less than 1000 and an IOB value of 0.3 to 0.5. . More preferably, (i) a polar oil having an organic value of 200-600 and an IOB value of 0.3-0.5, and (ii) an organic value of 1100-1300 and an IOB value of 0.3-0. N-acylamino acid ester of 5, and more preferably (i) a polar oil having an organic value of 250 to 450 and an IOB value of 0.3 to 0.5, and (ii) an organic value of An N-acyl amino acid ester having an IOB value of 1 to 1250 and an IOB value of 0.3 to 0.5 is used in combination.
(B)(i)有機性値が700以下のIOB値で0.3〜0.5の極性油としては、高級脂肪酸多価アルコールエステル、ジカルボン酸エステル、高級脂肪酸エステル、高級アルコール及び乳酸エステルから選ばれる有機性値が700以下でIOB値が0.3〜0.5の極性油が挙げられる。具体的にはイソステアリン酸プロピレングリコール(無機性値:166、有機性値:410、IOB値:0.4)、オレイン酸プロピレングリコール(無機性値:162、有機性値:420、IOB値:0.39)、ジオクタン酸エチレングリコール(無機性値:120、有機性値:340、IOB値:0.35)、ジカプリン酸ジエチレングリコール(無機性値:195、有機性値:480、IOB値:0.41)、ジカプロン酸プロピレングリコール(無機性値:120、有機性値:300、IOB値:0.4)、ジミリスチン酸グリセリル(無機性値:220、有機性値:620、IOB値:0.35)、ジヤシ油脂肪酸グリセリル(無機性値:220、有機性値:540、IOB値:0.41)、ジラウリン酸グリセリル(無機性値:220、有機性値:540、IOB値:0.41)、ジラウリン酸ジエチレングリコール(無機性値:195、有機性値:560、IOB値:0.35)、ジラウリン酸ポリエチレングリコール(無機性値:270、有機性値:600、IOB値:0.45)、ジ酢酸モノステアリン酸グリセリル(無機性値:180、有機性値:500、IOB値:0.36)、セスキオレイン酸グリセリル(無機性値:243、有機性値:600、IOB値:0.41)、セバシン酸ジイソプロピル(無機性値:120、有機性値:300、IOB値:0.4)、セバシン酸ジエチル(無機性値:120、有機性値:280、IOB値:0.43)、トリ(カプリル・カプリン酸)グリセリル(無機性値:180、有機性値:540、IOB値:0.33)、トリ2−エチルへキサン酸グリセリル(無機性値:180、有機性値:510、IOB値:0.35)、トリオクタン酸トリメチロールプロパン(無機性値:180、有機性値:550、IOB値:0.33)、トリカプリル酸グリセリル(無機性値:180、有機性値:540、IOB値:0.33)、パルミチン酸エチレングリコール(無機性値:160、有機性値:360、IOB値:0.44)、ヒマシ油脂肪酸メチル(無機性値:162、有機性値:380、IOB値:0.43)、ミリスチルアルコール(無機性値:100、有機性値:280、IOB値:0.36)、モノオレイン酸エチレングリコール(無機性値:162、有機性値:400、IOB値:0.41)、モノステアリン酸エチレングリコール(無機性値:160、有機性値:400、IOB値:0.4)、モノステアリン酸プロピレングリコール(無機性値:160、有機性値:420、IOB値:0.38)、ヤシ油アルコール(無機性値:100、有機性値:240、IOB値:0.42)、ラウリルアルコール(無機性値:100、有機性値:240、IOB値:0.42)、乳酸オクチルドデシル(無機性値:160、有機性値:450、IOB値:0.36)、乳酸オレイル(無機性値:162、有機性値:420、IOB値:0.39)、乳酸セチル(無機性値:160、有機性値:380、IOB値:0.42)等を例示することができる。 (B) (i) A polar oil having an organic value of 700 or less and an IOB value of 0.3 to 0.5 includes higher fatty acid polyhydric alcohol ester, dicarboxylic acid ester, higher fatty acid ester, higher alcohol and lactic acid ester. Examples include polar oils having an organic value of 700 or less and an IOB value of 0.3 to 0.5. Specifically, propylene glycol isostearate (inorganic value: 166, organic value: 410, IOB value: 0.4), propylene glycol oleate (inorganic value: 162, organic value: 420, IOB value: 0) 39), ethylene glycol dioctanoate (inorganic value: 120, organic value: 340, IOB value: 0.35), diethylene glycol dicaprate (inorganic value: 195, organic value: 480, IOB value:. 41), propylene glycol dicaproate (inorganic value: 120, organic value: 300, IOB value: 0.4), glyceryl dimyristate (inorganic value: 220, organic value: 620, IOB value: 0.00). 35), glyceryl dicoconut oil fatty acid (inorganic value: 220, organic value: 540, IOB value: 0.41), glyceryl dilaurate (inorganic value) 220, organic value: 540, IOB value: 0.41), diethylene glycol dilaurate (inorganic value: 195, organic value: 560, IOB value: 0.35), polyethylene glycol dilaurate (inorganic value: 270) , Organic value: 600, IOB value: 0.45), glyceryl monostearate (inorganic value: 180, organic value: 500, IOB value: 0.36), glyceryl sesquioleate (inorganic value) : 243, organic value: 600, IOB value: 0.41), diisopropyl sebacate (inorganic value: 120, organic value: 300, IOB value: 0.4), diethyl sebacate (inorganic value: 120) , Organic value: 280, IOB value: 0.43), tri (capryl / capric acid) glyceryl (inorganic value: 180, organic value: 540, IOB value: 0.3) ), Glyceryl tri-2-ethylhexanoate (inorganic value: 180, organic value: 510, IOB value: 0.35), trimethylolpropane trioctanoate (inorganic value: 180, organic value: 550, IOB) Value: 0.33), glyceryl tricaprylate (inorganic value: 180, organic value: 540, IOB value: 0.33), ethylene glycol palmitate (inorganic value: 160, organic value: 360, IOB value) : 0.44), castor oil fatty acid methyl (inorganic value: 162, organic value: 380, IOB value: 0.43), myristyl alcohol (inorganic value: 100, organic value: 280, IOB value: 0) .36), ethylene glycol monooleate (inorganic value: 162, organic value: 400, IOB value: 0.41), ethylene glycol monostearate (inorganic value: 160, organic value: 400, IOB value: 0.4), propylene glycol monostearate (inorganic value: 160, organic value: 420, IOB value: 0.38), coconut oil alcohol (inorganic value: 100, organic value: 240, IOB value: 0.42, lauryl alcohol (inorganic value: 100, organic value: 240, IOB value: 0.42), octyldodecyl lactate (inorganic value: 160, organic) Property value: 450, IOB value: 0.36), oleyl lactate (inorganic value: 162, organic value: 420, IOB value: 0.39), cetyl lactate (inorganic value: 160, organic value: 380) , IOB value: 0.42) and the like.
これらのうち、特に溶解性の高さや、乳化後の製剤の安定性の点から、好ましくはセバシン酸ジエチル、イソステアリン酸プロピレングリコール、乳酸オクチルドデシル、ジカプリン酸プロピレングリコール、セバシン酸ジイソプルであり、さらに好ましくは乳酸オクチルドデシル、ジカプリン酸プロピレングリコール、セバシン酸ジイソプロピルである。 Among these, particularly from the viewpoint of high solubility and stability of the preparation after emulsification, diethyl sebacate, propylene glycol isostearate, octyldodecyl lactate, propylene glycol dicaprate, and diisopure sebacate are more preferable. Are octyldodecyl lactate, propylene glycol dicaprate, diisopropyl sebacate.
(B)(i)有機性値が700以下のIOB値が0.3〜0.5の極性油の含有量は、皮膚外用剤総量に対し、安定性、官能特性の点から、1〜30質量%であることが好ましく、より好ましくは1〜10質量%であり、さらに好ましくは3〜10質量%である。 (B) (i) The content of the polar oil having an organic value of 700 or less and an IOB value of 0.3 to 0.5 is 1 to 30 in terms of stability and sensory characteristics with respect to the total amount of the external preparation for skin. It is preferable that it is mass%, More preferably, it is 1-10 mass%, More preferably, it is 3-10 mass%.
(B)(ii)有機性値が1000以上のIOB値が0.3〜0.5のN−アシルアミノ酸エステルは、N−アシルアミノ酸とアルコール類とのエステルである。N−アシルアミノ酸部分としては特に限定されないが、N−アシルアスパラギン酸又はN−アシルグルタミン酸であるN−アシル酸性アミノ酸であることが望ましく、さらに望ましくは、N−アシルグルタミン酸のものが用いられる。これらのアミノ酸構造は光学活性体又はラセミ体のいずれであってもよい。アシル基としては炭素数8〜22の飽和又は不飽和脂肪酸より誘導されるアシル基であることが望ましく、例えばラウリン酸,パルミチン酸,ステアリン酸,オレイン酸等の単一組成の脂肪酸によるアシル基の他に、ヤシ油脂肪酸,牛脂脂肪酸,硬化牛脂脂肪酸等の天然より得られる混合脂肪酸あるいは合成により得られる脂肪酸(分枝脂肪酸を含む)のアシル基であってもよい。 (B) (ii) An N-acyl amino acid ester having an organic value of 1000 or more and an IOB value of 0.3 to 0.5 is an ester of an N-acyl amino acid and an alcohol. Although it does not specifically limit as an N-acylamino acid part, It is desirable that it is N-acyl acidic amino acid which is N-acyl aspartic acid or N-acyl glutamic acid, More preferably, the thing of N-acyl glutamic acid is used. These amino acid structures may be either optically active or racemic. The acyl group is preferably an acyl group derived from a saturated or unsaturated fatty acid having 8 to 22 carbon atoms. For example, the acyl group of a fatty acid having a single composition such as lauric acid, palmitic acid, stearic acid, oleic acid, etc. In addition, it may be a mixed fatty acid obtained from nature such as coconut oil fatty acid, beef tallow fatty acid, hardened beef tallow fatty acid, or an acyl group of fatty acids (including branched fatty acids) obtained by synthesis.
エステル生成残基としては、特に限定されないが、ステロール、炭素数8〜30の液状高級アルキル若しくはアルケニルアルコール、炭素数12〜38の固形状高級アルキルアルコールなどが望ましく用いられる。N−アシル酸性アミノ酸エステルの場合、モノエステル体であってもジエステル体であっても構わないが、2つのエステル生成残基のうち少なくとも一方がステロール残基であるジエステル体であることが特に望ましい。ステロールとしては、動物由来のものであっても植物由来のものであってもよく、例えばコレステロール、フィトステロール又はこれらの水添物等を挙げることができる。また、炭素数8〜30の液状高級アルキル若しくはアルケニルアルコールは炭素数8〜30の天然又は合成脂肪族アルコールでかつ常温で液状を呈するものであり、例えば2−オクチルドデシルアルコール等の分枝アルコール、オレイルアルコール等の不飽和アルコールなどが挙げられる。炭素数12〜38の固形状高級アルキルアルコールは炭素数12〜38の飽和一価アルコールでかつ常温で固形状を呈するもので、例えばセチルアルコール,ベヘニルアルコールなどが挙げられる。 The ester-forming residue is not particularly limited, but sterol, liquid higher alkyl or alkenyl alcohol having 8 to 30 carbon atoms, solid higher alkyl alcohol having 12 to 38 carbon atoms, and the like are desirably used. In the case of an N-acyl acidic amino acid ester, it may be a monoester or a diester, but is particularly preferably a diester in which at least one of two ester-generating residues is a sterol residue. . The sterol may be animal-derived or plant-derived, and examples thereof include cholesterol, phytosterol, and hydrogenated products thereof. The liquid higher alkyl or alkenyl alcohol having 8 to 30 carbon atoms is a natural or synthetic aliphatic alcohol having 8 to 30 carbon atoms and exhibits a liquid state at room temperature, for example, a branched alcohol such as 2-octyldodecyl alcohol, Examples thereof include unsaturated alcohols such as oleyl alcohol. Solid higher alkyl alcohols having 12 to 38 carbon atoms are saturated monohydric alcohols having 12 to 38 carbon atoms and exhibit a solid form at room temperature, and examples thereof include cetyl alcohol and behenyl alcohol.
これらのN−アシルアミノ酸エステルは、1種又は2種以上を組み合わせて用いられ、好ましくはエステル残基としてステロール残基を有するものを含むことが望ましい。 These N-acyl amino acid esters are used alone or in combination of two or more, and preferably include those having a sterol residue as an ester residue.
具体的には、N−ラウロイル−L−グルタミン酸ジ(フィトステリル・2−オクチルドデシル)(無機性値:369、有機性値:1214、IOB値:0.3)、N−ラウロイル−L−グルタミン酸ジ(コレステリル・ベヘニル・オクチルドデシル)(無機性値:369、有機性値:1218、IOB値:0.3)、N−ラウロイル−L−グルタミン酸ジ(コレステリル・オクチルドデシル)(無機性値:369、有機性値:1198、IOB値:0.3)、N−ラウロイル−L−グルタミン酸ジ(フィトステリル・ベヘニル・2−オクチルドデシル)(無機性値:369、有機性値:1236、IOB値:0.3)等を挙げることができる。これらのうち、特に好ましくはN−ラウロイル−L−グルタミン酸ジ(フィトステリル・2−オクチルドデシル)である。 Specifically, N-lauroyl-L-glutamate di (phytosteryl 2-octyldodecyl) (inorganic value: 369, organic value: 1214, IOB value: 0.3), N-lauroyl-L-glutamate di (Cholesteryl behenyl octyldodecyl) (inorganic value: 369, organic value: 1218, IOB value: 0.3), N-lauroyl-L-glutamate di (cholesteryl octyldodecyl) (inorganic value: 369, Organic value: 1198, IOB value: 0.3), N-lauroyl-L-glutamate di (phytosteryl, behenyl, 2-octyldodecyl) (inorganic value: 369, organic value: 1236, IOB value: 0. 3). Of these, N-lauroyl-L-glutamate di (phytosteryl 2-octyldodecyl) is particularly preferable.
これらの(B)(ii)N−アシルアミノ酸エステルは、一般に市販されており、味の素株式会社より販売されている「エルデュウPS203」(N−ラウロイル−L−グルタミン酸ジ(フィトステリル/オクチルデシル))、「エルデュウCL−301」(N−ラウロイルグルタミン酸ジ(コレステリル/ベヘニル/オクチルドデシル))、「エルデュウCl−202」(N−ラウロイルグルタミン酸ジ(コレステリル/オクチルドデシル))、「エルデュウPS−304」(N−ラウロイルグルタミン酸ジ(フィトステリル/ベヘニル/オクチルドデシル))、「エルデュウPS−306」などが例示できる。 These (B) (ii) N-acylamino acid esters are generally commercially available and are sold by Ajinomoto Co., Inc., “Eldue PS203” (N-lauroyl-L-glutamate di (phytosteryl / octyldecyl)), “Eldue CL-301” (N-lauroyl glutamate di (cholesteryl / behenyl / octyldodecyl)), “Eldue Cl-202” (N-lauroyl glutamate di (cholesteryl / octyldodecyl)), “Eldue PS-304” (N -Lauroylglutamate di (phytosteryl / behenyl / octyldodecyl)), "Erudu PS-306", etc. can be illustrated.
(B)(ii)N−アシルアミノ酸エステルは単独で用いてもよいし、2種以上を混合して用いてもよい。(B)(ii)N−アシルアミノ酸エステルの含有量は、皮膚外用剤総量に対して、安定性、官能特性の点から、0.05〜10質量%が好ましく、より好ましくは0.1〜5質量%、さらに好ましくは0.1〜3質量%である。 (B) (ii) N-acylamino acid esters may be used alone or in admixture of two or more. The content of (B) (ii) N-acylamino acid ester is preferably 0.05 to 10% by mass, more preferably 0.1 to 10% from the viewpoint of stability and sensory characteristics with respect to the total amount of the external preparation for skin. It is 5 mass%, More preferably, it is 0.1-3 mass%.
本発明における(C)ポリアクリルアミド化合物は、アクリルアミドならびにそれらの誘導体のホモポリマーまたはコポリマーの群から選ばれる1種又は2種以上のポリマーである。ポリアクリルアミド化合物には、ポリアクリルアミド、アクリルアミドコポリマーが含まれる。ポリアクリルアミドコポリマーとしては、アクリルアミド及び/又はアクリロイルジメチルタウリンを構成単位として含むコポリマーが挙げられる。 The (C) polyacrylamide compound in the present invention is one or more polymers selected from the group of homopolymers or copolymers of acrylamide and derivatives thereof. The polyacrylamide compound includes polyacrylamide and acrylamide copolymer. Examples of the polyacrylamide copolymer include a copolymer containing acrylamide and / or acryloyldimethyltaurine as a structural unit.
ポリアクリルアミド及びそのコポリマーとしては、(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、(アクリル酸Na/アクリロイルジメチルタウリン)コポリマー、ポリアクリルアミド、ポリアクリル酸Na、(アクリルアミド/アクリル酸アンモニウム)コポリマー等が挙げられる。 Examples of polyacrylamide and copolymers thereof include (hydroxyethyl acrylate / acryloyl dimethyl taurine Na) copolymer, (Na acrylate / acryloyl dimethyl taurine) copolymer, polyacrylamide, polyacrylic acid Na, (acrylamide / ammonium acrylate) copolymer, and the like. Can be mentioned.
(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマーとしては、例えばSEPPIC社のセピノブEMT10もしくは複合原料であるSEPPIC社のSIMULGEL NS((アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、スクワラン、ポリソルベート60、水;(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマーを35〜40質量%含有)を用いることができる。 Examples of the (hydroxyethyl acrylate / acryloyldimethyltaurine Na) copolymer include, for example, sepinobu EMT10 from SEPPIC or SIMULGEL NS ((hydroxyethyl acrylate / acryloyldimethyltaurine Na) copolymer, squalane, polysorbate 60, which is a composite material. Water (containing 35 to 40% by mass of a copolymer of hydroxyethyl acrylate / acryloyldimethyltaurine Na) can be used.
(アクリル酸Na/アクリロイルジメチルタウリン)コポリマーとしては、例えば、SEPPIC社の複合原料であるSIMULGEL EG((アクリル酸Na/アクリロイルジメチルタウリン)コポリマー、イソヘキサデカン、ポリソルベート80、水;(アクリル酸Na/アクリロイルジメチルタウリン)コポリマーを37.5質量%含有)、SIMULGEL EPG((アクリル酸Na/アクリロイルジメチルタウリン)コポリマー、ポリイソブテン、(カプリリル/カプリル)グルコシド、水)等を用いることができる。 Examples of the (Na / acryloyl dimethyl taurate acrylate) copolymer include SIMULGEL EG ((Na acrylate / acryloyl dimethyl taurine) copolymer, isohexadecane, polysorbate 80, water; water; (Na / acryloyl acrylate). Dimethyl taurine) copolymer (containing 37.5% by mass), SIMULGEL EPG ((Na acrylate / acryloyl dimethyl taurine) copolymer, polyisobutene, (caprylyl / capryl) glucoside, water) and the like can be used.
ポリアクリルアミドとしては、例えば2−アクリルアミド−2−メチルプロパンスルホン酸の架橋コポリマーが挙げられ、例えばSEPPIC社の複合原料であるセピゲル305(ポリアクリルアミド、水添ポリイソブテン、ラウレス−7、水;ポリアクリルアミドを40質量%含有)、セピゲル501(ポリアクリルアミド、ポリソルベート85、ミネラルオイル、イソパラフィン;ポリアクリルアミドを20質量%含有)を用いることができる。 Examples of polyacrylamide include a cross-linked copolymer of 2-acrylamido-2-methylpropanesulfonic acid. For example, Sepigel 305 (polyacrylamide, hydrogenated polyisobutene, laureth-7, water; 40% by mass) and Sepigel 501 (polyacrylamide, polysorbate 85, mineral oil, isoparaffin; containing 20% by mass of polyacrylamide) can be used.
(アクリルアミド/アクリル酸アンモニウム)コポリマーとしてはSEPPIC社の複合原料であるSEPIPLUS 265((アクリルアミド/アクリル酸アンモニウム)コポリマー、ポリイソブテン、ポリソルベート20、水)等を用いることができる。 As the (acrylamide / ammonium acrylate) copolymer, SEPPIC 265 ((acrylamide / ammonium acrylate) copolymer, polyisobutene, polysorbate 20, water), which is a composite material of SEPPIC, can be used.
これらの(C)ポリアクリルアミド化合物としては、より好ましくはポリアクリルアミド又はアクリルアミドコポリマーであり、特に好ましくは(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、(アクリル酸Na/アクリロイルジメチルタウリン)コポリマー、ポリアクリルアミドである。これらを用いると、溶出イオンによる影響を受けにくく、安定性に優れる。 These (C) polyacrylamide compounds are more preferably polyacrylamide or acrylamide copolymers, and particularly preferably (hydroxyethyl acrylate / acryloyldimethyltaurine Na) copolymer, (Naacrylate / acryloyldimethyltaurine) copolymer, poly Acrylamide. When these are used, they are hardly affected by the eluted ions and have excellent stability.
(C)ポリアクリルアミド化合物の含有量は、皮膚外用剤総量に対して、安定性、官能特性の点から、0 .05〜5質量%が好ましく、より好ましくは0.1〜4質量%であり、さらに好ましくは0.15〜2.5質量%である。 (C) The content of the polyacrylamide compound is 0. 0 from the viewpoint of stability and sensory characteristics with respect to the total amount of the external preparation for skin. 05-5 mass% is preferable, More preferably, it is 0.1-4 mass%, More preferably, it is 0.15-2.5 mass%.
前記成分(B)と成分(C)の含有質量比〔(B):(C)〕は、べたつき感、きしみ感の抑制の点から、50:1〜2:1が好ましく、より好ましくは20:1〜5:1である。 The mass ratio of component (B) to component (C) [(B) :( C)] is preferably 50: 1 to 2: 1 and more preferably 20 from the viewpoint of suppression of stickiness and squeak. : 1 to 5: 1.
本発明における(D)リン脂質としては、リン脂質中ホスファチジルコリン含量が60質量%以上であるリン脂質を使用するのが好ましい。より好ましくはホスファチジルコリン含量が65質量%以上のリン脂質、さらに好ましくはホスファチジルコリン含量が70質量%以上のリン脂質である。ホスファチジルコリン以外のリン脂質成分としては、ホスファチジン酸、ホスファチジルセリン、ホスファチジルエタノールアミン、ホスファチジルイノシトール、ホスファチジルグリセロールなどが挙げられる。 As the phospholipid (D) in the present invention, it is preferable to use a phospholipid having a phosphatidylcholine content of 60% by mass or more in the phospholipid. More preferred is a phospholipid having a phosphatidylcholine content of 65% by mass or more, and further preferred is a phospholipid having a phosphatidylcholine content of 70% by mass or more. Examples of phospholipid components other than phosphatidylcholine include phosphatidic acid, phosphatidylserine, phosphatidylethanolamine, phosphatidylinositol, and phosphatidylglycerol.
本発明に用いられるリン脂質は、動植物から抽出、精製した天然物であっても、化学合成したものであっても良く、水素添加、水酸化処理などの加工を施しても良い。天然物としては、大豆又は卵黄等からの抽出・精製物であるレシチンが、市販品の入手が容易であり、好ましい。より好ましいリン脂質としては、エマルションの安定性向上の点から、水素添加又は水酸化処理されたリン脂質であり、大豆レシチン水素添加物、卵黄レシチン水素添加物が好適に挙げられる。 The phospholipid used in the present invention may be a natural product extracted and purified from animals and plants, or may be chemically synthesized, and may be subjected to processing such as hydrogenation or hydroxylation. As a natural product, lecithin, which is an extract / purified product from soybean or egg yolk, is preferable because it is easy to obtain a commercial product. More preferable phospholipids are phospholipids that have been hydrogenated or hydroxylated from the viewpoint of improving the stability of the emulsion, and examples thereof include soybean lecithin hydrogenated products and egg yolk lecithin hydrogenated products.
リン脂質中のホスファチジルコリンの含有率は、薄層クロマトグラフィー(TLC)や高速液体クロマトフラフィー(HPLC)、イアトロスキャン(ヤトロン社製)等を用いた方法で分析することができる。例えば、特開2001−186898号公報に記載されるリン脂質が含まれる有機溶媒をTLCにスポットしてクロロホルム:メタノール:酢酸=65:25:10で展開し、50wt%硫酸エタノールを噴霧、加熱後デンシトメーターでリン脂質を分析する方法が挙げられる。前記方法以外でも、リン脂質中に含まれるホフファチジルコリンの含有量、含有率を測定、算出できる方法であれば、いずれの方法でも良い。 The content of phosphatidylcholine in the phospholipid can be analyzed by a method using thin layer chromatography (TLC), high performance liquid chromatography (HPLC), Iatroscan (manufactured by Yatron) or the like. For example, an organic solvent containing phospholipid described in JP-A-2001-186898 is spotted on TLC, developed with chloroform: methanol: acetic acid = 65: 25: 10, sprayed with 50 wt% ethanol sulfate, and after heating A method of analyzing phospholipids with a densitometer is mentioned. In addition to the above method, any method may be used as long as it can measure and calculate the content and content of phosphatidylcholine contained in the phospholipid.
ホスファチジルコリンを60質量%以上含有しているリン脂質としては、コートソームNC−21(水素添加大豆レシチン;日油社製)、レシノールS−10E、レシノールS−10EX(水素添加大豆レシチン;日光ケミカルズ社製)等を挙げることができる。 Examples of phospholipids containing 60% by mass or more of phosphatidylcholine include coatsome NC-21 (hydrogenated soybean lecithin; manufactured by NOF Corporation), resinol S-10E, and resinol S-10EX (hydrogenated soybean lecithin; Nikko Chemicals). Manufactured).
(D)リン脂質は単独で用いてもよいし、2種以上を混合して用いてもよい。(D)リン脂質の含有量は、皮膚外用剤総量に対して、安定性、官能特性の点から、0.0001〜20質量%が好ましく、より好ましくは0.001〜15質量%、さらに好ましくは0.01〜12質量%、さらに好ましくは0.01〜5質量%である。 (D) A phospholipid may be used independently and may be used in mixture of 2 or more types. (D) The content of the phospholipid is preferably 0.0001 to 20% by mass, more preferably 0.001 to 15% by mass, and still more preferably, from the viewpoint of stability and sensory characteristics with respect to the total amount of the external preparation for skin. Is 0.01 to 12% by mass, more preferably 0.01 to 5% by mass.
本発明皮膚外用剤では、さらなる良好な感触を得る点から、さらに(E)質量平均分子量が1000〜20000の高重合ポリエチレングリコールを含有することが好ましい。好ましくは質量平均重合度が2000〜11000であり、より好ましくは質量平均重合度が3000〜6000のものである。 In the external preparation for skin of the present invention, it is preferable to further contain (E) a highly polymerized polyethylene glycol having a mass average molecular weight of 1000 to 20000 from the viewpoint of obtaining a better feel. The mass average degree of polymerization is preferably 2000 to 11000, and more preferably 3000 to 6000.
<質量平均分子量の測定>
質量平均分子量(Mw)は、高速液体クロマトグラフィーを使用し、ゲルパーミエーションクロマトグラフィー(GPC)法によって測定することができる。この場合、標準サンプルとして分子量106、194、440、600、1470、4100、7100、10300、12600、23000の10種のポリエチレングリコールを用いて較正曲線を求め、その較正曲線を基に、ポリエチレングリコールの質量平均分子量(Mw)を求めることができる。
<Measurement of mass average molecular weight>
The mass average molecular weight (Mw) can be measured by gel permeation chromatography (GPC) method using high performance liquid chromatography. In this case, a calibration curve is obtained by using 10 kinds of polyethylene glycols having molecular weights of 106, 194, 440, 600, 1470, 4100, 7100, 10300, 12600, and 23000 as standard samples. The mass average molecular weight (Mw) can be determined.
これらの高重合ポリエチレングリコールとしては、具体的には、POLYOX WSR N−10、POLYOX WSR N−12K(Amerchol社製)、RITA PEO−1、RITA PEO−2(Rita社製)、PEG#2000、PEG#4000、PEG#6000(日油社製)の商品名で市販されている。これら高重合ポリエチレングリコールの中から、一種又は二種以上を適宜選択して用いることができる As these highly polymerized polyethylene glycols, specifically, POLYOX WSR N-10, POLYOX WSR N-12K (manufactured by Amerchol), RITA PEO-1, RITA PEO-2 (manufactured by Rita), PEG # 2000, It is commercially available under the trade names of PEG # 4000 and PEG # 6000 (manufactured by NOF Corporation). From these highly polymerized polyethylene glycols, one or two or more can be appropriately selected and used.
(E)高重合ポリエチレングリコールの含有量は、皮膚外用剤総量に対して、安定性、官能特性の点から、0.1〜5質量%が好ましく、より好ましくは0.5〜3質量%であり、さらに好ましくは0.5〜2質量%である。 (E) The content of the highly polymerized polyethylene glycol is preferably 0.1 to 5% by mass, more preferably 0.5 to 3% by mass with respect to the total amount of the external preparation for skin, from the viewpoint of stability and sensory characteristics. Yes, and more preferably 0.5-2% by mass.
本発明の皮膚外用剤には上記の成分の他に、水;水溶性色素;パラベン、フェノキシエタノールなどの防腐剤;セチル硫酸ナトリウム、N−ステアロイル−L−グルタミン酸塩などの陰イオン界面活性剤;多価アルコール脂肪酸エステル、ポリグリセリン脂肪酸エステル、変性シリコーン、ショ糖脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレン脂肪酸エステルなどの非イオン界面活性剤;テトラアルキルアンモニウム塩などの陽イオン界面活性剤;ベタイン型、スルホベタイン型、スルホアミノ酸型などの両性界面活性剤;セレブロシドなどの天然系界面活性剤;ジブチルヒドロキシトルエンなどの抗酸化剤;塩化ナトリウム、塩化マグネシウム、硫酸ナトリウム、硝酸カリウム、リン酸カリウム、リン酸ナトリウム、等の無機塩類;クエン酸、クエン酸ナトリウム、酢酸カリウム、琥珀酸ナトリウム、アスパラギン酸ナトリウム、乳酸ナトリウム、カルニチン塩、ガンマアミノ酪酸、リポ酸等の有機酸塩類;塩酸エタノールアミン、硝酸アンモニウム、塩酸アルギニン等の塩類、エデト酸等のキレート剤;水酸化カリウム、ジイソプロパノールアミン、トリエタノールアミン等の中和剤;コラーゲン等の生体高分子;胎盤抽出物;ヒドロキシメトキシベンゾフェノンスルフォン酸塩等の紫外線吸収剤;パルミチン酸アスコルビル、ステアリン酸アスコルビル、テトライソステアリン酸アスコルビルなどの油溶性ビタミンC誘導体;キサンタンガム、ベータグルカン、オーツ麦、白きくらげ等から抽出される多糖類、カラギーナンやアルギン酸、寒天などのような海藻より抽出されるもの、カルボキシビニルポリマー、ペクチン、アルキル変性カルボキシビニルポリマーなどの水溶性高分子等を配合することができる。 In addition to the above components, the topical skin preparation of the present invention includes water; water-soluble dyes; preservatives such as paraben and phenoxyethanol; anionic surfactants such as sodium cetyl sulfate and N-stearoyl-L-glutamate; Nonionic surfactants such as monohydric alcohol fatty acid esters, polyglycerin fatty acid esters, modified silicones, sucrose fatty acid esters, polyoxyethylene hydrogenated castor oil, polyoxyethylene fatty acid esters; cationic surfactants such as tetraalkylammonium salts; Amphoteric surfactants such as betaine type, sulfobetaine type and sulfoamino acid type; natural surfactants such as cerebroside; antioxidants such as dibutylhydroxytoluene; sodium chloride, magnesium chloride, sodium sulfate, potassium nitrate, potassium phosphate, Sodium triphosphate Inorganic salts such as, citric acid, sodium citrate, potassium acetate, sodium oxalate, sodium aspartate, organic acid salts such as sodium lactate, carnitine salt, gamma aminobutyric acid, lipoic acid; ethanolamine hydrochloride, ammonium nitrate, arginine hydrochloride Salts such as edetic acid, etc .; neutralizing agents such as potassium hydroxide, diisopropanolamine and triethanolamine; biopolymers such as collagen; placental extract; ultraviolet absorbers such as hydroxymethoxybenzophenone sulfonate Oil-soluble vitamin C derivatives such as ascorbyl palmitate, ascorbyl stearate, ascorbyl tetraisostearate; polysaccharides extracted from xanthan gum, beta glucan, oats, white jellyfish, carrageenan, alginic acid, agar, etc. Those extracted from seaweed, such as carboxyvinyl polymers, pectins, water-soluble polymers such as alkyl-modified carboxyvinyl polymer may be blended.
本発明の皮膚外用剤には、さらに植物、海藻又は菌体の抽出物を用いることができ、例えばアーティチョーク、アイ、アルニカ、アロエ、アルテア、アシタバ、アセロラ、アンズ、アーモンド、アマチャ、アケビ、アニス、アボカド、インチンコウ、イラクサ、イチゴ、ウイキョウ、ウコン、ウチワサボテン、ウーロン茶、ウスベニアオイ、エイジツ、エチナシ、エンバク、エンメイソウ、エーデルワイス、オランダカラシ、オウバク、オウゴン、オウレン、オオバナサルスベリ、オトギリソウ、オレンジ、オクラ、オリーブ葉、カシス、カノコソウ、柿、火棘、カミツレ、カムカム、カロット、カワラヨモギ、カラスムギ、甘草、キュウカンバー、キョウニン、キウイ、キナ、キラヤ、キズタ、ギャバ茶、木苺、クララ、クマザサ、クワ、クルミ、グレープフルーツ、ゲンノショウコ、ゲンチアナ、ゲツトウ、コヒラタムブツ、ゴボウ、コンフリー、小麦胚芽、サクラ、サボンソウ、サルビア、サンザシ、サイシン、サイタイ、サンシシ、シモツケソウ、ジュウヤク、シチヘンゲ、ショウブ、ショウガ、シコン、シソ、シラカバ、シャクヤク、ジオウ、シーカーサー、シモン、スギナ、スターフルーツ、ゼニアオイ、センキュウ、セイヨウサンザシ、セイヨウキズタ、セイヨウナシ、セイヨウシロヤナギ、セージ、センブリ、ダイズ、ダイダイ、タイム、タチバナ、タチジャコウソウ、タマリンド、茶、チョウジ、チンピ、椿、ドクダミ、トウキ、トウニン、トウヒ、トマト、トウキセンカ、藤茶、トルメンチラ、トウモロコシ、ニーム、ニガハッカ、ニワトコ、ニンニク、ニンジン、ノバラ、パプアメース、ハイビスカス、パセリ、バナナ、バラ、ハトムギ、ハウチワマメ、ピーカンナッツ、ヒノキ、ヒソップ、ヒマラヤンラズベリー、ヒメフウロ、ビャクダン、ビルベリー、ビワ、プルーン、ブドウ、フサザキスイセン、フサフジウツギ、フトモモ、ペパーミント、ベニバナ、ヘチマ、ヘラオオバコ、ホワイトジェネピ、ホウノキ、菩提樹、ボタンボウフウ、ボタン、ホップ、ホホバ、マルメロ、マイカイカ、マロニエ、マツ、ミカン、ムクロジ、メリッサ、メマツヨイグサ、モモ、モミジ、ヤグルマソウ、ユキノシタ、ユーカリ、ユリ、柚、ヨクイニン、ヨモギ、ラン、ライム、ラベンダーレタス、リンゴ、リュウキュウヨモギ、ルイボス、レンゲソウ、レモン、レモンバーム、ローズヒップ、ローズマリー、緑藻、紅藻、褐藻、ブクリョウ、シイタケ、クリタケ、サルノコシカケ、シロキクラゲ、レイシ、冬虫夏草、酵母、乳酸菌、根粒菌の全草、葉、茎、根、果実、種子、花、子実体、菌体から水、あるいはグリセリン、プロピレングリコール、エタノール、ブチレングリコール等の有機溶媒、或いはその混液等で抽出された抽出物である。葉緑素も植物抽出物に該当する。また生乳、果汁、合成培地、半合成培地を用いた乳酸菌、酵母の培養液を菌体の除去の有無に関わらず用いることができる。 For the skin external preparation of the present invention, a plant, seaweed or fungus extract can be further used. For example, artichoke, eye, arnica, aloe, altea, ashitaba, acerola, apricot, almond, amateur, akebi, anise, Avocado, Ginseng, Nettle, Strawberry, Fennel, Turmeric, Prickly Pear, Oolong Tea, Usenia Oy, Ages, Echinacea, Oat, Emperor, Edelweiss, Dutch Mustard, Aubergine, Ogon, Ouren, Greater Cranberry, Orange Hypericum, Leaf Cassis, valerian, persimmon, fire thorn, chamomile, cam cam, carrot, oakworm, oats, licorice, cucumber, kyounin, kiwi, kina, kiraya, kizuta, gabba tea, mallet, clara, kumazasa, mulberry, Lumi, Grapefruit, Gentian Ginger, Gentian, Getto, Kohiratambutsu, Burdock, Comfrey, Wheat Germ, Cherry, Salmon, Salvia, Hawthorn, Saishin, Saitai, Sanshi, Shimotake, Shiyaku, Shichihenge, Shobu, Ginger, Shiba, Shiso Peonies, Giants, Seekers, Simon, Horsetails, Star Fruits, Zeniahoi, Senkyu, Prunus Hawthorn, Prunus Kizuta, Pears, White Willow, Sage, Assembly, Soybean, Daidai, Thyme, Tachibana, Tachikaku, Tamarind, Tea, Clove, Chimpi, persimmon, dokudami, touki, tonin, spruce, tomato, tokisenka, wisteria tea, tormentilla, corn, neem, nigahakka, elderberry, garlic, nin , Wild rose, papuames, hibiscus, parsley, banana, rose, pearl barley, hachiwame, pecan nut, cypress, hyssop, himalayan raspberry, peafowl, sandalwood, bilberry, loquat, prunes, grapes, chrysanthemum, chrysanthemum, peppermint, peppermint , Safflower, loofah, hera plantain, white genepi, cypress, linden tree, button bowfish, button, hop, jojoba, quince, squid, melon, maroon, pine, mandarin orange, melissa, melissa, evening primrose, peach, maple, cornflower, cypress Lily, persimmon, yokuinin, mugwort, orchid, lime, lavender lettuce, apple, ryukyu mugwort, rooibos, forsythia, lemon, lemon balm, rosehip, rosemary, green algae , Red algae, brown algae, broomfish, shiitake mushrooms, mushrooms, Sarno mushrooms, white jellyfish, litchi, cordyceps, yeast, lactic acid bacteria, rhizobial whole plants, leaves, stems, roots, fruits, seeds, flowers, fruit bodies, body to water, Or it is an extract extracted with organic solvents, such as glycerol, propylene glycol, ethanol, butylene glycol, or its liquid mixture. Chlorophyll is also a plant extract. In addition, lactic acid bacteria and yeast culture solutions using raw milk, fruit juice, synthetic medium, and semi-synthetic medium can be used regardless of whether or not the cells are removed.
本発明の皮膚外用剤の用途としては、特に制限がなく、化粧料、医薬品、医薬部外品等に好適に用いることができる。具体的には、洗顔料、クレンジング化粧料、ローション、乳液、美容クリーム、下地化粧料、日焼け止め化粧料、パック、マッサージ化粧料などの皮膚化粧料、各種薬剤を含有する軟膏、クリーム等の外用医薬品として好適に利用できる。特に本発明の皮膚外用剤は、保湿感の持続性に優れることから、洗い流さず、皮膚に保持するタイプの皮膚外用剤として用いることが好ましい。 There is no restriction | limiting in particular as a use of the skin external preparation of this invention, It can use suitably for cosmetics, a pharmaceutical, a quasi-drug, etc. Specifically, for external use such as facial cleansers, cleansing cosmetics, lotions, emulsions, beauty creams, base cosmetics, sunscreen cosmetics, packs, massage cosmetics and other skin cosmetics, ointments containing various drugs, creams, etc. It can be suitably used as a medicine. In particular, since the external preparation for skin of the present invention is excellent in the moisturizing feeling, it is preferably used as a type of external preparation for skin that is not washed away and is retained on the skin.
本発明の皮膚外用剤の剤形は、特に制限されず、液状、エマルション、ジェル状、スプレー状、ムース状等のものとして調製される。 The dosage form of the external preparation for skin of the present invention is not particularly limited, and is prepared as a liquid, emulsion, gel, spray, mousse or the like.
以下、実施例及び比較例に基づいて本発明を詳細に説明するが、これらに限定されるものではない。まず、実施例及び比較例で用いた皮膚外用剤の安定性試験、官能試験、保湿性試験について下記に説明する。 EXAMPLES Hereinafter, although this invention is demonstrated in detail based on an Example and a comparative example, it is not limited to these. First, the stability test, sensory test, and moisture retention test of the external preparation for skin used in Examples and Comparative Examples will be described below.
〔安定性試験〕
各試料を恒温槽にて5℃で6ヶ月保存した後、試料を顕微鏡で観察し、結晶化の有無を確認し、安定性を評価した。また、恒温槽にて40℃で6ヶ月保存した後、試料の外観観察を行い、安定性を評価した。
[Stability test]
Each sample was stored in a thermostatic bath at 5 ° C. for 6 months, and then the sample was observed with a microscope to confirm the presence or absence of crystallization and to evaluate the stability. Moreover, after preserve | saving for 6 months at 40 degreeC in a thermostat, the external appearance observation of the sample was performed and stability was evaluated.
〔安定性試験(5℃)評価基準〕
○:結晶なし
△:僅かに結晶あり
×:結晶あり
〔安定性試験(40℃)評価基準〕
○:外観変化なし
△:一部に油浮きが見られる
×:完全に分離している
[Stability test (5 ° C) evaluation criteria]
○: No crystals Δ: Slightly crystals ×: Crystals [Stability test (40 ° C) evaluation criteria]
○: No change in appearance △: Part of oil floating is observed ×: Completely separated
〔官能試験〕
10名の評価パネラーに試料を使用してもらい、塗布後のべたつき感、きしみ感についてそれぞれ評価した。
[Sensory test]
Ten evaluation panelists used the samples, and evaluated the stickiness and squeakiness after application.
〔官能試験の評価基準〕
1.べたつき感
◎:10名中9人以上がべたつきを感じないと回答
○:10名中7、8名がべたつきを感じないと回答
△:10名中5、6名がべたつきを感じないと回答
×:10名中5名未満がべたつきを感じないと回答
2.きしみ感
◎:10名中9人以上がきしみを感じないと回答
○:10名中8、9名がきしみを感じないと回答
△:10名中6、7名がきしみを感じないと回答
×:10名中5名未満がきしみを感じないと回答
[Evaluation criteria for sensory tests]
1. Stickiness ◎: Nine or more of the 10 respondents do not feel sticky ○: Seven or eight of the ten respondents do not feel sticky △: Five or ten of the ten respondents do not feel sticky × : Less than 5 out of 10 feel no stickiness 2. Sense of squeezing ◎: 9 or more out of 10 responded that they did not feel squeezed ○: 8 out of 10 responded that they did not feel squeezed △: 6 out of 10 responded that they did not feel squeaky × : Less than 5 out of 10 responded that they did not feel squeak
〔保湿性試験〕角質層水分量の測定
10人の上腕部において、実施例及び比較例で用いた組成物を一定量塗布し、塗布前、塗布1時間後、及び3時間後の角質水分量を田上らの方法に基づきSkicon−200(IBS社製)を用いて測定し、塗布後の数値の上昇した人数にて評価を行った。
[Moisture retention test] Measurement of stratum corneum moisture content A certain amount of the composition used in Examples and Comparative Examples was applied to the upper arm of 10 people, and the stratum corneum moisture content before application, 1 hour after application, and 3 hours after application. Was measured using Skicon-200 (manufactured by IBS Co., Ltd.) based on the method of Tagami et al.
○:10名中8名以上の数値が上昇した
△:10名中5〜7名の数値が上昇した
×:10名中5名未満の数値が上昇した
○: The numerical value of 8 or more out of 10 people increased △: The numerical value of 5-7 out of 10 people increased ×: The numerical value of less than 5 out of 10 people increased
実施例1〜9、比較例1〜6 Examples 1-9, Comparative Examples 1-6
実施例及び比較例で用いた組成と、前記安定性試験結果及び官能試験結果を表1に合わせて示す。 Table 1 shows the compositions used in the examples and comparative examples, and the stability test results and sensory test results.
本発明の実施例1〜9の試料は5℃6ヵ月保存後も比較的安定であった。一方、比較例1〜6では、調製直後はなめらかに調製されているが、5℃6ヵ月保存後は、結晶が確認されたり、40℃6ヶ月保管後に分離が見られたりした。また、実施例1〜9の試料は保湿感があるにもかかわらず、べたつき感及びきしみ感を感じないのに対し、一方、比較例1〜6はこれらの使用感でも劣っていた。 The samples of Examples 1 to 9 of the present invention were relatively stable after storage at 5 ° C. for 6 months. On the other hand, in Comparative Examples 1-6, although it was prepared smoothly immediately after preparation, after storage at 5 ° C for 6 months, crystals were confirmed, or separation was observed after storage at 40 ° C for 6 months. Moreover, although the samples of Examples 1-9 had a moisturizing feeling, they did not feel sticky and squeaky, whereas Comparative Examples 1-6 were inferior in their feeling of use.
応用例1 乳液
1.パルミチン酸 0.1
2.水素添加大豆リン脂質 0.4
3.2’−ジヒドロキシ−5,5’−ジ−n−プロピルビフェニル
0.5
4.イソステアリン酸 0.6
5.ジプロピレングリコール 3.0
6.コレステロール 0.2
7.セバシン酸ジイソプロピル 3.0
8.ミリスチン酸オクチルドデシル 1.0
9.1,3−ブチレングリコール 3.0
10.エデト酸二ナトリウム 0.02
11.カルボキシビニルポリマー 0.02
12.ケルトロール 0.03
13.フェノキシエタノール 0.3
14.エタノール 6.0
15.SEPIGEL 305(SEPPIC社製) 0.17
16.香料 0.05
17.火棘抽出物(*1) 0.1
18.キョウニンエキス(*2) 0.1
19.加水分解コンキオリン液(*3) 0.1
20.オウバクエキス(*4) 0.1
21.加水分解シルク液(*5) 0.1
22.精製水 残部
(*1)火棘(サントリー社製)
(*2)キョウニン抽出液LA(丸善製薬社製)
(*3)真珠たん白抽出液K(丸善製薬社製)
(*4)オウバク抽出液J(丸善製薬社製)
(*5)シルクプロテインエキスK(一丸ファルコス社製)
Application Example 1 Emulsion Palmitic acid 0.1
2. Hydrogenated soybean phospholipid 0.4
3.2'-Dihydroxy-5,5'-di-n-propylbiphenyl
0.5
4). Isostearic acid 0.6
5. Dipropylene glycol 3.0
6). Cholesterol 0.2
7). Diisopropyl sebacate 3.0
8). Octyldodecyl myristate 1.0
9.1,3-Butylene glycol 3.0
10. Edetate disodium 0.02
11. Carboxyvinyl polymer 0.02
12 Celtic roll 0.03
13. Phenoxyethanol 0.3
14 Ethanol 6.0
15. SEPIGEL 305 (manufactured by SEPPIC) 0.17
16. Fragrance 0.05
17. Fire thorn extract (* 1) 0.1
18. Kyonin extract (* 2) 0.1
19. Hydrolyzed conchiolin solution (* 3) 0.1
20. Oat extract (* 4) 0.1
21. Hydrolyzed silk solution (* 5) 0.1
22. Purified water balance (* 1) Fire thorn (Suntory)
(* 2) Kyonin extract LA (Maruzen Pharmaceutical Co., Ltd.)
(* 3) Pearl protein extract K (Maruzen Pharmaceutical Co., Ltd.)
(* 4) Awaku extract J (Maruzen Pharmaceutical Co., Ltd.)
(* 5) Silk protein extract K (Ichimaru Falcos)
(製造方法)
(1)成分1〜9を80℃に加熱し、均一に混合する。
(2)成分10〜12および24を80℃に加熱し、均一に混合する。
(3)(1)に、(2)を80℃に加熱保持しながら、徐々に添加して均一に混合させる。
(4)(3)を40℃まで徐々に冷却し、成分13〜23を40℃で添加し、均一に混合させる。
(Production method)
(1) Components 1 to 9 are heated to 80 ° C. and mixed uniformly.
(2) Heat components 10-12 and 24 to 80 ° C. and mix uniformly.
(3) While (2) is heated and maintained at 80 ° C., it is gradually added to (1) and mixed uniformly.
(4) (3) is gradually cooled to 40 ° C, and components 13 to 23 are added at 40 ° C and mixed uniformly.
応用例2 クリーム
1.マカデミアナッツ油脂肪酸コレステリル 2.0
2.ベヘニルアルコール 1.5
3.フィトステロール 0.4
4.植物性スクワラン 4.0
5.ミリスチン酸オクチルドデシル 2.5
6.水素添加大豆リン脂質 0.5
7.イソステアリン酸プロピレングリコール 5.0
8.2,2’−ジヒドロキシ−5,5’−ジ−n−プロピルビフェニル
0.7
9.(2S,3R)−2−オクタデカノイルアミノオクタデカン−1,3−ジオール
0.1
10.濃グリセリン 3.0
11.1,3−ブチレングリコール 2.0
12.ジプロピレングリコール 5.0
13.エデト酸二ナトリウム 0.12
14.カルボキシビニルポリマー 0.24
15.PEG−75 2.0
16.SIMULGEL EG(SEPPIC社製) 2.56
17.サンショウ抽出液 (*6) 0.1
18.酵母エキス (*7) 0.1
19.海草エキス (*8) 0.1
20.甜茶エキス (*9) 0.1
21.チンピエキス (*10) 0.1
22.シーグラスエキス (*11) 0.1
23.加水分解シルク液 0.1
24.月桃葉エキス (*12) 0.1
25.N−アセチルグルコサミン (*13) 0.1
26.香料 0.05
27.フェノキシエタノール 0.4
28.エタノール 3.0
29.精製水 残部
(*6)サンショウ抽出液−J(丸善製薬社製)
(*7)サイトダイン(ブルックス インダストリー社製)
(*8)LAMINAINE−BG(Biotech Marine社製)
(*9)甜茶抽出液BGW(丸善製薬社製)
(*10)チンピエキスK65B(日油社製)
(*11)エメラス(テクノーブル社製)
(*12)月桃葉抽出液BG(丸善製薬社製)
(*13)マリンスウィートF(焼津水産化学工業社製)
Application Example 2 Cream Macadamia nut oil fatty acid cholesteryl 2.0
2. Behenyl alcohol 1.5
3. Phytosterol 0.4
4). Plant-based squalane 4.0
5. Octyldodecyl myristate 2.5
6). Hydrogenated soybean phospholipid 0.5
7). Propylene glycol isostearate 5.0
8. 2,2′-Dihydroxy-5,5′-di-n-propylbiphenyl
0.7
9. (2S, 3R) -2-Octadecanoylaminooctadecane-1,3-diol
0.1
10. Concentrated glycerin 3.0
11.1,3-butylene glycol 2.0
12 Dipropylene glycol 5.0
13. Edetate disodium 0.12
14 Carboxyvinyl polymer 0.24
15. PEG-75 2.0
16. SIMULGEL EG (manufactured by SEPPIC) 2.56
17. Salamander extract (* 6) 0.1
18. Yeast extract (* 7) 0.1
19. Seaweed extract (* 8) 0.1
20. Green tea extract (* 9) 0.1
21. Chimpi extract (* 10) 0.1
22. Seagrass extract (* 11) 0.1
23. Hydrolyzed silk solution 0.1
24. Moon peach leaf extract (* 12) 0.1
25. N-acetylglucosamine (* 13) 0.1
26. Fragrance 0.05
27. Phenoxyethanol 0.4
28. Ethanol 3.0
29. Purified water balance (* 6) Salamander extract-J (Maruzen Pharmaceutical Co., Ltd.)
(* 7) Sightdyne (manufactured by Brooks Industry)
(* 8) LAMINAINE-BG (manufactured by Biotech Marine)
(* 9) Green tea extract BGW (Maruzen Pharmaceutical Co., Ltd.)
(* 10) Chimpi extract K65B (manufactured by NOF Corporation)
(* 11) Emerals (Technoble)
(* 12) Moon peach leaf extract BG (Maruzen Pharmaceutical Co., Ltd.)
(* 13) Marine Sweet F (made by Yaizu Suisan Chemical Co., Ltd.)
(製造方法)
(1)成分1〜12を80℃に加熱し、均一に混合する。
(2)成分13〜15および31を80℃に加熱し、均一に混合する。
(3)(1)に、(2)を80℃に加熱保持しながら、徐々に添加して均一に混合させる。
(4)(3)を40℃まで徐々に冷却し、成分16〜30を40℃で添加し、均一に混合させる。
(Production method)
(1) Components 1 to 12 are heated to 80 ° C. and mixed uniformly.
(2) Components 13 to 15 and 31 are heated to 80 ° C. and mixed uniformly.
(3) While (2) is heated and maintained at 80 ° C., it is gradually added to (1) and mixed uniformly.
(4) (3) is gradually cooled to 40 ° C, and components 16 to 30 are added at 40 ° C and mixed uniformly.
応用例3 サンスクリーン
1.エタノール 20.0
2.ミリスチン酸イソセチル 3.0
3.パラメトキシケイ皮酸2−エチルヘキシル 5.0
4.2,4,6−トリス〔4−(2−エチルヘキシルオキシカルボニル)アニリノ〕−1,3,5−トリアジン 2.0
5.セバシン酸ジイソプロピル 5.0
6.4−tert−ブチル−4’−メトキシジベンゾイルメタン 1.0
7.水素添加大豆リン脂質 0.05
8.ラウロイルグルタミン酸ジ(コレステリル/オクチルドデシル)
0.5
9.PEG−75 0.5
10.濃グリセリン 3.0
11.キサンタンガム 0.1
12.エデト酸二ナトリウム 0.02
13.茶の実エキス (*14) 0.001
14.ホエイ (*15) 0.1
15.ディオスコレアコンポジタエキス (*16) 0.1
16.シャクヤクエキス (*17) 0.1
17.トウキエキス (*18) 0.1
18.SEPIPLUS 265(SEPPIC社製) 1.5
19.香料 0.07
20.精製水 残部
(*14)茶の実抽出物(丸善製薬社製)
(*15)ホエイCPA(一丸ファルコス社製)
(*16)デイオスコレアコンポジタ根エキス(三井化学社製)
(*17)シャクヤク抽出液BG−JC(丸善製薬社製)
(*18)トウキ抽出液LA−S(丸善製薬社製)
Application Example 3 Sunscreen Ethanol 20.0
2. Isocetyl myristate 3.0
3. 2-Ethylhexyl paramethoxycinnamate 5.0
4.2,4,6-Tris [4- (2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine 2.0
5. Diisopropyl sebacate 5.0
6. 4-tert-butyl-4′-methoxydibenzoylmethane 1.0
7). Hydrogenated soybean phospholipid 0.05
8). Lauroyl glutamate di (cholesteryl / octyldodecyl)
0.5
9. PEG-75 0.5
10. Concentrated glycerin 3.0
11. Xanthan gum 0.1
12 Edetate disodium 0.02
13. Tea seed extract (* 14) 0.001
14 Whey (* 15) 0.1
15. Dioscorea compositor extract (* 16) 0.1
16. Peonies extract (* 17) 0.1
17. Toki extract (* 18) 0.1
18. SEPIPLUS 265 (manufactured by SEPPIC) 1.5
19. Perfume 0.07
20. Purified water remainder (* 14) Tea fruit extract (Maruzen Pharmaceutical Co., Ltd.)
(* 15) Whey CPA (made by Ichimaru Falcos)
(* 16) Deioscorea compositor root extract (Mitsui Chemicals)
(* 17) Peonies extract BG-JC (Maruzen Pharmaceutical Co., Ltd.)
(* 18) Toki extract LA-S (Maruzen Pharmaceutical Co., Ltd.)
(製造方法)
(1)成分1〜9および19を、均一に混合する。
(2)成分20〜17および20を、均一に混合する。
(3)(1)に、(2)を、徐々に添加して均一に混合させる。
(4)(3)が均一になったら、成分18を添加し、均一に混合させる。
(Production method)
(1) Components 1 to 9 and 19 are mixed uniformly.
(2) Components 20 to 17 and 20 are mixed uniformly.
(3) To (1), (2) is gradually added and mixed uniformly.
(4) When (3) becomes uniform, component 18 is added and mixed uniformly.
Claims (4)
(A)コレステロール及びフィトステロールよりなる群から選択される1種以上
(B)次の(i)及び(ii)を含有するIOB値が0.3〜0.5の極性油
(i)有機性値が250〜450の極性油 3〜10質量%
(ii)有機性値が1000以上のN−アシルアミノ酸エステル 0.1〜3質量%
(C)ポリアクリルアミド化合物
(D)リン脂質 A skin external preparation containing the following components (A) to (D), wherein the mass ratio of component (B) to component (C) [(B) :( C)] is 20: 1 to 5: 1 .
(A) One or more selected from the group consisting of cholesterol and phytosterols (B) Polar oils having an IOB value of 0.3 to 0.5 containing the following (i) and (ii) (i) Organic values Is 3 to 10% by weight of polar oil of 250 to 450
(Ii) 0.1 to 3% by mass of an N-acyl amino acid ester having an organic value of 1000 or more
(C) Polyacrylamide compound (D) Phospholipid
(ii)有機性値が1150〜1250のN−アシルアミノ酸エステルを含有するものである請求項1に記載の皮膚外用剤。 Component (B) is (i) a polar oil having an organic value of 250 to 450,
(Ii) The skin external preparation according to claim 1, which contains an N-acylamino acid ester having an organic value of 1150 to 1250.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016026822A JP6106777B2 (en) | 2016-02-16 | 2016-02-16 | Topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016026822A JP6106777B2 (en) | 2016-02-16 | 2016-02-16 | Topical skin preparation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011177414A Division JP5917043B2 (en) | 2011-08-15 | 2011-08-15 | Skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016094481A JP2016094481A (en) | 2016-05-26 |
JP6106777B2 true JP6106777B2 (en) | 2017-04-05 |
Family
ID=56070122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016026822A Active JP6106777B2 (en) | 2016-02-16 | 2016-02-16 | Topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6106777B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018123002A1 (en) * | 2016-12-28 | 2018-07-05 | 小林製薬株式会社 | Topical composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571503A (en) * | 1995-08-01 | 1996-11-05 | Mausner; Jack | Anti-pollution cosmetic composition |
JP2000086434A (en) * | 1998-09-11 | 2000-03-28 | Kose Corp | Cosmetic |
KR101925354B1 (en) * | 2009-10-23 | 2018-12-05 | 다우 코닝 도레이 캄파니 리미티드 | Novel co-modified organopolysiloxane |
-
2016
- 2016-02-16 JP JP2016026822A patent/JP6106777B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016094481A (en) | 2016-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5917043B2 (en) | Skin preparation | |
JP5826171B2 (en) | Oil-in-water emulsion composition | |
JP6352560B2 (en) | External composition containing ascorbic acid and / or salt thereof | |
JP5563420B2 (en) | Aqueous cosmetics | |
JP5690074B2 (en) | Cosmetics containing ceramide derivatives | |
KR20160100931A (en) | Stick-shaped base material containing lipid-peptide compound | |
JP7063265B2 (en) | Creamy composition | |
JP5693245B2 (en) | Topical skin preparation | |
JP5894791B2 (en) | Gel skin external preparation | |
WO2020111067A1 (en) | Composition containing ether from aliphatic alcohol and glycerin | |
JP2019514954A (en) | Method for improving the moisturizing state of human skin epidermis in a short period of time; Novel moisturizing composition | |
JP5825934B2 (en) | Gel skin external preparation | |
JP6053359B2 (en) | Emulsified composition and method for producing the same | |
JP6106777B2 (en) | Topical skin preparation | |
JP2011173825A (en) | Ascorbic acid derivative | |
JP2015189723A (en) | Ceramide-containing external preparation composition | |
JP4672328B2 (en) | Skin external preparation containing ascorbic acid derivative salt, method for stabilizing skin external preparation, and stabilizer | |
JP5102944B2 (en) | Topical skin preparation | |
US20190247290A1 (en) | Composition containing linoleic acid | |
JP2005089427A (en) | Skin care preparation for external use | |
WO2020230691A1 (en) | Composition containing ceramide and isobutyl oleate | |
JP2010229074A (en) | Ascorbic acid derivative | |
JP2017081883A (en) | External preparation for skin | |
DE102014222570A1 (en) | Shower lotions I | |
JP4698236B2 (en) | Hair growth cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160316 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170123 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170228 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170306 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 6106777 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |